Literature DB >> 7888544

Recurrent infection due to Legionella pneumophila in a patient with AIDS.

J N Morley1, L C Smith, A L Baltch, R P Smith.   

Abstract

We report a patient with AIDS who presented with community-acquired cavitary Legionella pneumophila pneumonia. The patient recovered after an extended course of treatment with macrolide antibiotics. He returned to the hospital 4 months later with a febrile illness. Chest radiograms appeared normal. Cultures of blood yielded L. pneumophila. The isolate from blood was indistinguishable from the isolate from sputum taken during the first infection, as shown by restriction-endonuclease analysis and pulsed-field gel electrophoresis. These data suggest that the second infection represented reactivation of a persistent focus of infection that was not apparent when the patient had pneumonia.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7888544     DOI: 10.1093/clinids/19.6.1130

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  6 in total

1.  Hospital-acquired pneumonia and bacteremia caused by Legionella pneumophila in an immunocompromised patient.

Authors:  C-C Lai; C-K Tan; C-H Chou; H-L Hsu; Y-T Huang; C-H Liao; P-R Hsueh
Journal:  Infection       Date:  2010-03-26       Impact factor: 3.553

2.  Serum cytokines in patients with Legionella pneumonia: relative predominance of Th1-type cytokines.

Authors:  K Tateda; T Matsumoto; Y Ishii; N Furuya; A Ohno; S Miyazaki; K Yamaguchi
Journal:  Clin Diagn Lab Immunol       Date:  1998-05

3.  Inhibitory and bactericidal activities of levofloxacin, ofloxacin, erythromycin, and rifampin used singly and in combination against Legionella pneumophila.

Authors:  A L Baltch; R P Smith; W Ritz
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

4.  Antibacterial effects of levofloxacin, erythromycin, and rifampin in a human monocyte system against Legionella pneumophila.

Authors:  A L Baltch; R P Smith; M A Franke; P B Michelsen
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

5.  Factors related to persistence of Legionella urinary antigen excretion in patients with legionnaires' disease.

Authors:  N Sopena; M Sabrià; M L Pedro-Botet; E Reynaga; M García-Núñez; J Domínguez; L Matas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2002-12-10       Impact factor: 3.267

6.  Improvements to the Success of Outbreak Investigations of Legionnaires' Disease: 40 Years of Testing and Investigation in New York State.

Authors:  Dianna Schoonmaker-Bopp; Elizabeth Nazarian; David Dziewulski; Ernest Clement; Deborah J Baker; Michelle C Dickinson; Amy Saylors; Neculai Codru; Lisa Thompson; Pascal Lapierre; Nellie Dumas; Ronald Limberger; Kimberlee A Musser
Journal:  Appl Environ Microbiol       Date:  2021-07-27       Impact factor: 4.792

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.